AI-Powered Biomarker Discovery in Drug Development
The pharmaceutical industry stands at the precipice of a revolutionary transformation, where artificial intelligence converges with biological discovery to reshape how we identify, validate, and utilize biomarkers in drug development. This technological evolution represents more than incremental progress; it fundamentally redefines the boundaries of what’s possible in pharmaceutical research and personalized medicine. The integration of…